Press release
Antibody Production Market size to Reach USD 37.73 Billion by 2031, Driven by Expanding Biologics Demand and Rising Diagnostic Applications
Mordor Intelligence has published a new report on the antibody production market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Antibody Production Market Overview
According to Mordor Intelligence, the antibody production market size [https://www.mordorintelligence.com/industry-reports/antibody-production-market?utm_source=abnewswire] is expected to grow from USD 19.17 billion in 2025 to USD 21.46 billion in 2026 and further reach USD 37.73 billion by 2031. This steady antibody production market growth reflects increasing reliance on antibody-based treatments and research tools across global healthcare systems.
The antibody production industry is witnessing growing demand from pharmaceutical companies, biotechnology firms, and research institutions. Antibodies are essential in targeted therapies, particularly in oncology, autoimmune diseases, and infectious disease management. In addition, diagnostic laboratories are increasingly adopting antibodies for accurate and early disease detection, contributing to the overall antibody production market share.
Antibody Production Market Trends Shaping Industry Growth
Rising Demand for Targeted Biologics
One of the key antibody production market trends is the increasing use of targeted biologics. Pharmaceutical companies focus on therapies that specifically bind to disease-causing cells while minimizing impact on healthy tissues. This approach is driving demand for monoclonal and engineered antibodies, strengthening antibody production market growth.
Growing Adoption of Bispecific and Multispecific Antibodies
The antibody production industry is also seeing a rise in bispecific and multispecific antibody formats. These antibodies can bind to multiple targets simultaneously, improving treatment outcomes. Their growing adoption in clinical pipelines is expanding the antibody production market size and creating new opportunities for manufacturers and technology providers.
Expansion of Diagnostic Applications
Diagnostic laboratories are playing a larger role in the antibody production market. Antibodies are widely used in diagnostic kits and laboratory assays for disease detection and monitoring. This trend is increasing antibody production market share across non-therapeutic applications and strengthening the overall antibody production market forecast.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/antibody-production-market?utm_source=abnewswire
Antibody Production Market Segmentation Analysis
By Product
*
Consumables
*
Instruments
By Process
*
Upstream Processing
*
Downstream Processing
By Antibody Type
*
Monoclonal Antibodies
*
Polyclonal Antibodies
*
Bispecific Antibodies
*
Antibody Fragments
By End User
*
Pharmaceutical and Biotechnology Companies
*
Contract Manufacturing and Research Organizations
*
Academic and Government Research Institutes
*
Diagnostic Laboratories
By Geography
*
North America
*
Europe
*
Asia-Pacific
*
Middle East and Africa
*
South America
Antibody Production Market Competitive Landscape and Key Players
The antibody production market is moderately concentrated, with several global players holding a strong position through integrated offerings and wide distribution networks. Companies are focusing on expanding their capabilities through partnerships, acquisitions, and technology development to strengthen their antibody production market share.
Key Players in the Antibody Production Market
*
Sartorius AG
*
Danaher Corporation
*
Merck KGaA
*
Eppendorf AG
*
Thermo Fisher Scientific
Conclusion
The antibody production market is expected to maintain a strong growth trajectory as demand for biologics continues to rise across healthcare and research sectors. The increasing use of antibodies in targeted therapies and diagnostics is supporting steady antibody production market growth and expanding the antibody production industry.
Key antibody production market trends such as the adoption of advanced antibody formats, increased use of single-use systems, and integration of artificial intelligence are improving production efficiency and scalability. These developments are helping companies meet growing demand while maintaining quality and consistency.
Industry Related Reports
Next-Generation Antibody Therapeutics Market:
The market is expanding due to increasing focus on targeted therapies, rising prevalence of chronic diseases such as cancer, and advancements in antibody drug conjugates and biologic technologies.
Get more insights: https://www.mordorintelligence.com/industry-reports/next-generation-antibody-therapeutics-market?utm_source=abnewswire
Antibody Fragments Market size:
The market is valued at USD 7.85 billion in 2025 and is projected to reach USD 10.98 billion by 2030, driven by growing demand for targeted biologics, improved therapeutic efficacy, and advancements in fragment-based drug development.
Get more insights: https://www.mordorintelligence.com/industry-reports/antibody-fragments-market?utm_source=abnewswire
Antibody Discovery Market share:
The market is valued at USD 9.09 billion in 2025 and is expected to reach USD 15.45 billion by 2030, supported by increasing R&D investments, rising demand for novel biologics, and technological advancements in antibody screening and development platforms.
Get more insights: https://www.mordorintelligence.com/industry-reports/antibody-discovery-market?utm_source=abnewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com https://www.mordorintelligence.com/
Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=antibody-production-market-size-to-reach-usd-3773-billion-by-2031-driven-by-expanding-biologics-demand-and-rising-diagnostic-applications]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Production Market size to Reach USD 37.73 Billion by 2031, Driven by Expanding Biologics Demand and Rising Diagnostic Applications here
News-ID: 4434160 • Views: …
More Releases from ABNewswire
Dicyclopentadiene Market Size to Grow at Over 5.5% CAGR Through 2030 Driven by R …
The "Dicyclopentadiene Market" Insights report offers an in-depth and thorough analysis of the market, covering aspects such as size, shares, revenues, segments, drivers, trends, growth, and development. Additionally, it identifies factors that may limit growth and examines regional industrial presence that could influence market trends beyond 2031.
Dicyclopentadiene Market Overview and Introduction
According to Mordor Intelligence, the dicyclopentadiene market size [https://www.mordorintelligence.com/industry-reports/dicyclopentadiene-market?utm_source=abnewswire] is expected to expand at a CAGR of over 5.5% during…
Conviso Inc. Obtains a Perfect CMMC Level 2 Assessment Score!
March 21, 2026 - Luray, Virginia - We are excited to announce Conviso Inc, has achieved a perfect score on our Cybersecurity Maturity Model Certification (CMMC) Level 2 Assessment conducted by a third-party assessment organization. Conviso achieves this certification several months before the requirement for a third-party assessment is required. Receiving this certification reflects our company's unwavering commitment to resilience and excellence in cybersecurity.
Conviso's President, Uday Malhan, stated, "This was…
The True Cost of Risk for Small Businesses in 2026
Image: https://www.abnewswire.com/upload/2026/03/640fdd5f927fe5107872da1d9242a5f0.jpg
Most small business owners don't think of risk as a line item until it starts quietly eating into their margins.
It rarely shows up all at once. Instead, it creeps in through delayed projects, unexpected expenses, minor incidents, and missed opportunities. A shipment arrives late. A piece of equipment fails. A small dispute turns into a costly interruption. On their own, these moments seem manageable. Together, they can significantly impact…
AstroIdeal and the Economics of Trust: How Europe's Leading Spiritual Services P …
The Spanish online spiritual services market reached an estimated 340 million in revenue in 2025, growing at a 12.3% compound annual growth rate. Within this rapidly expanding sector, one company has established a commanding lead that financial analysts describe as a textbook case of competitive moat building. AstroIdeal, with an estimated 15% market share, more than 2.5 million completed consultations, and financial metrics that rival the best-performing digital services companies…
More Releases for Antibody
OBP2A Antibody Market Thrives on Technological Innovations in Antibody Productio …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global OBP2A Antibody Market- (By Type (Polyclonal Antibodies, and Monoclonal Antibodies; By Application-(Enzyme Linked Immunosorbent Assay, Immunohistochemistry, & Western Blot)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global OBP2A Antibody Market is valued at US$ 102.9 Mn in 2023, and it is expected to…
Evolving Market Trends In The Antibody Drug Conjugates Industry: Regulation On A …
The Antibody Drug Conjugates Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Antibody Drug Conjugates Market Size During the Forecast Period?
The market size for antibody drug conjugates has experienced rapid expansion in the past few years. It's projected to rise from…
TIGIT Antibody Clinical Trials FDA Approval Market Size Anti TGIT Antibody Sales …
Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028 Report Highlights:
• Anti TIGIT Antibodies In Clinical Trials: > 50 Antibodies
• First Anti TIGIT Antibody To Get Approval Within Next 5 Years
• Global Anti TIGIT Antibodies Clinical Pipeline Insight By Company, Indication and Phase
• Insight On More Than 50 Anti TIGIT Antibodies In Clinical Trials
• Anti TIGIT Antibodies Market Trends by Indication & Country
• Global Anti TIGIT Antibodies Market Dynamics
Download Report:
https://www.kuickresearch.com/report-anti-tigit-antibody-anti-tigit-antibodies-fda-approved-tigit-antibody-tigit-inhibitors-tigit-drugs-approved-tigit-expression-tigit-ligand-tigit-gene
In recent years, the global…
Mammalian Polyclonal IgG Antibody Market, Mammalian Polyclonal IgG Antibody Mark …
"According to the research report, the global inspection machines market was valued at USD 845.21 million in 2022 and is expected to reach USD 1,437.59 million by 2032, to grow at a CAGR of 5.5% during the forecast period."
Request Our Free Sample Report for Inspection Machines Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market/request-for-sample
Report Overview
Polaris Market Research, a leading global market research and consulting company, has recently published its latest report…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
The combination antibody therapy market is expected to experience significant growth in the coming years. Combination antibody therapy involves the use of two or more monoclonal antibodies (mAbs) in combination to treat various diseases, such as cancer, autoimmune disorders, and infectious diseases.
Request For Free Sample Report of "Combination Antibody Therapy Market"@ https://www.persistencemarketresearch.com/samples/11740
Combination antibody therapy has several potential benefits over single-agent therapies, including increased efficacy, improved patient outcomes, and reduced toxicity.…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
Combination antibody therapy involves the use of two or more antibodies to target and treat a specific disease or condition. This type of therapy is often used in cancer treatment, as it can be more effective at targeting and killing cancer cells than single-antibody therapies. Combination antibody therapy can also be used to treat a range of other diseases and conditions, including autoimmune diseases, infectious diseases, and allergic conditions.
Request For…
